Evogene (EVGN) Tops Q4 EPS by 66c

Evogene (NASDAQ: EVGN) reported Q4 EPS of $0.06, $0.66 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $1.61 million versus the consensus estimate of $5.4 million.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Full Circle Lithium closes $5.14M private placement
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August